- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.42 Å
- Oligo State
- hetero-15-15-mer
- Ligands
- 15 x 0SM: TRIMETHYL-[2-[[(2S,3S)-2-(OCTADECANOYLAMINO)-3-OXIDANYL-BUTOXY]-OXIDANYL-PHOSPHORYL]OXYETHYL]AZANIUM(Non-covalent)
- 15 x PC7: (7S)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE(Non-covalent)
PC7.2: 14 residues within 4Å:- Chain A: A.414, L.417, A.418, A.419, G.421, V.441, H.442, F.445, G.446, F.449, R.450, V.490, L.494
- Chain B: E.9
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:L.417, A:L.417, A:F.445
- Hydrogen bonds: A:G.446
- Salt bridges: A:H.442, A:R.450
PC7.8: 13 residues within 4Å:- Chain C: L.417, A.418, A.419, G.421, H.442, F.445, G.446, F.449, R.450, L.482, A.486, V.490, L.494
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:L.482, C:L.482, C:V.490, C:V.490
- Salt bridges: C:H.442, C:R.450
PC7.12: 16 residues within 4Å:- Chain E: A.414, L.417, A.418, A.419, L.420, G.421, H.442, F.445, G.446, F.449, R.450, V.483, A.486, V.490, L.494
- Ligands: 0SM.11
4 PLIP interactions:4 interactions with chain E- Hydrophobic interactions: E:F.445, E:F.445
- Salt bridges: E:H.442, E:R.450
PC7.14: 14 residues within 4Å:- Chain G: A.414, L.417, A.418, A.419, G.421, V.441, H.442, F.445, G.446, F.449, R.450, V.490, L.494
- Chain H: E.9
6 PLIP interactions:6 interactions with chain G- Hydrophobic interactions: G:L.417, G:L.417, G:F.445
- Hydrogen bonds: G:G.446
- Salt bridges: G:H.442, G:R.450
PC7.20: 13 residues within 4Å:- Chain I: L.417, A.418, A.419, G.421, H.442, F.445, G.446, F.449, R.450, L.482, A.486, V.490, L.494
6 PLIP interactions:6 interactions with chain I- Hydrophobic interactions: I:L.482, I:L.482, I:V.490, I:V.490
- Salt bridges: I:H.442, I:R.450
PC7.24: 16 residues within 4Å:- Chain K: A.414, L.417, A.418, A.419, L.420, G.421, H.442, F.445, G.446, F.449, R.450, V.483, A.486, V.490, L.494
- Ligands: 0SM.23
4 PLIP interactions:4 interactions with chain K- Hydrophobic interactions: K:F.445, K:F.445
- Salt bridges: K:H.442, K:R.450
PC7.26: 14 residues within 4Å:- Chain M: A.414, L.417, A.418, A.419, G.421, V.441, H.442, F.445, G.446, F.449, R.450, V.490, L.494
- Chain N: E.9
6 PLIP interactions:6 interactions with chain M- Hydrophobic interactions: M:L.417, M:L.417, M:F.445
- Hydrogen bonds: M:G.446
- Salt bridges: M:H.442, M:R.450
PC7.32: 13 residues within 4Å:- Chain O: L.417, A.418, A.419, G.421, H.442, F.445, G.446, F.449, R.450, L.482, A.486, V.490, L.494
6 PLIP interactions:6 interactions with chain O- Hydrophobic interactions: O:L.482, O:L.482, O:V.490, O:V.490
- Salt bridges: O:H.442, O:R.450
PC7.36: 16 residues within 4Å:- Chain Q: A.414, L.417, A.418, A.419, L.420, G.421, H.442, F.445, G.446, F.449, R.450, V.483, A.486, V.490, L.494
- Ligands: 0SM.35
4 PLIP interactions:4 interactions with chain Q- Hydrophobic interactions: Q:F.445, Q:F.445
- Salt bridges: Q:H.442, Q:R.450
PC7.38: 14 residues within 4Å:- Chain S: A.414, L.417, A.418, A.419, G.421, V.441, H.442, F.445, G.446, F.449, R.450, V.490, L.494
- Chain T: E.9
6 PLIP interactions:6 interactions with chain S- Hydrophobic interactions: S:L.417, S:L.417, S:F.445
- Hydrogen bonds: S:G.446
- Salt bridges: S:H.442, S:R.450
PC7.44: 13 residues within 4Å:- Chain U: L.417, A.418, A.419, G.421, H.442, F.445, G.446, F.449, R.450, L.482, A.486, V.490, L.494
6 PLIP interactions:6 interactions with chain U- Hydrophobic interactions: U:L.482, U:L.482, U:V.490, U:V.490
- Salt bridges: U:H.442, U:R.450
PC7.48: 16 residues within 4Å:- Chain W: A.414, L.417, A.418, A.419, L.420, G.421, H.442, F.445, G.446, F.449, R.450, V.483, A.486, V.490, L.494
- Ligands: 0SM.47
4 PLIP interactions:4 interactions with chain W- Hydrophobic interactions: W:F.445, W:F.445
- Salt bridges: W:H.442, W:R.450
PC7.50: 14 residues within 4Å:- Chain Y: A.414, L.417, A.418, A.419, G.421, V.441, H.442, F.445, G.446, F.449, R.450, V.490, L.494
- Chain Z: E.9
6 PLIP interactions:6 interactions with chain Y- Hydrophobic interactions: Y:L.417, Y:L.417, Y:F.445
- Hydrogen bonds: Y:G.446
- Salt bridges: Y:H.442, Y:R.450
PC7.56: 13 residues within 4Å:- Chain 0: L.417, A.418, A.419, G.421, H.442, F.445, G.446, F.449, R.450, L.482, A.486, V.490, L.494
6 PLIP interactions:6 interactions with chain 0- Hydrophobic interactions: 0:L.482, 0:L.482, 0:V.490, 0:V.490
- Salt bridges: 0:H.442, 0:R.450
PC7.60: 16 residues within 4Å:- Chain 2: A.414, L.417, A.418, A.419, L.420, G.421, H.442, F.445, G.446, F.449, R.450, V.483, A.486, V.490, L.494
- Ligands: 0SM.59
4 PLIP interactions:4 interactions with chain 2- Hydrophobic interactions: 2:F.445, 2:F.445
- Salt bridges: 2:H.442, 2:R.450
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.3: 6 residues within 4Å:- Chain A: S.66, D.67, T.89, N.118, F.119, T.120
Ligand excluded by PLIPNAG.4: 2 residues within 4Å:- Chain A: N.154, S.156
Ligand excluded by PLIPNAG.5: 5 residues within 4Å:- Chain C: S.66, D.67, Y.90, N.118, T.120
Ligand excluded by PLIPNAG.6: 2 residues within 4Å:- Chain C: N.154, S.157
Ligand excluded by PLIPNAG.9: 7 residues within 4Å:- Chain E: S.66, D.67, T.89, Y.90, N.118, F.119, T.120
Ligand excluded by PLIPNAG.10: 3 residues within 4Å:- Chain E: N.154, S.156, S.157
Ligand excluded by PLIPNAG.15: 6 residues within 4Å:- Chain G: S.66, D.67, T.89, N.118, F.119, T.120
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain G: N.154, S.156
Ligand excluded by PLIPNAG.17: 5 residues within 4Å:- Chain I: S.66, D.67, Y.90, N.118, T.120
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain I: N.154, S.157
Ligand excluded by PLIPNAG.21: 7 residues within 4Å:- Chain K: S.66, D.67, T.89, Y.90, N.118, F.119, T.120
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain K: N.154, S.156, S.157
Ligand excluded by PLIPNAG.27: 6 residues within 4Å:- Chain M: S.66, D.67, T.89, N.118, F.119, T.120
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain M: N.154, S.156
Ligand excluded by PLIPNAG.29: 5 residues within 4Å:- Chain O: S.66, D.67, Y.90, N.118, T.120
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain O: N.154, S.157
Ligand excluded by PLIPNAG.33: 7 residues within 4Å:- Chain Q: S.66, D.67, T.89, Y.90, N.118, F.119, T.120
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain Q: N.154, S.156, S.157
Ligand excluded by PLIPNAG.39: 6 residues within 4Å:- Chain S: S.66, D.67, T.89, N.118, F.119, T.120
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain S: N.154, S.156
Ligand excluded by PLIPNAG.41: 5 residues within 4Å:- Chain U: S.66, D.67, Y.90, N.118, T.120
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain U: N.154, S.157
Ligand excluded by PLIPNAG.45: 7 residues within 4Å:- Chain W: S.66, D.67, T.89, Y.90, N.118, F.119, T.120
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain W: N.154, S.156, S.157
Ligand excluded by PLIPNAG.51: 6 residues within 4Å:- Chain Y: S.66, D.67, T.89, N.118, F.119, T.120
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain Y: N.154, S.156
Ligand excluded by PLIPNAG.53: 5 residues within 4Å:- Chain 0: S.66, D.67, Y.90, N.118, T.120
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain 0: N.154, S.157
Ligand excluded by PLIPNAG.57: 7 residues within 4Å:- Chain 2: S.66, D.67, T.89, Y.90, N.118, F.119, T.120
Ligand excluded by PLIPNAG.58: 3 residues within 4Å:- Chain 2: N.154, S.156, S.157
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Khare, B. et al., Structure of Usutu virus SAAR-1776 displays fusion loop asymmetry. Proc.Natl.Acad.Sci.USA (2021)
- Release Date
- 2021-09-01
- Peptides
- Envelope protein E: ACEGIKMOQSUWY02
Membrane protein M: BDFHJLNPRTVXZ13 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
EG
AI
CK
EM
AO
CQ
ES
AU
CW
EY
A0
C2
EB
BD
DF
FH
BJ
DL
FN
BP
DR
FT
BV
DX
FZ
B1
D3
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.42 Å
- Oligo State
- hetero-15-15-mer
- Ligands
- 15 x 0SM: TRIMETHYL-[2-[[(2S,3S)-2-(OCTADECANOYLAMINO)-3-OXIDANYL-BUTOXY]-OXIDANYL-PHOSPHORYL]OXYETHYL]AZANIUM(Non-covalent)
- 15 x PC7: (7S)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE(Non-covalent)
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Khare, B. et al., Structure of Usutu virus SAAR-1776 displays fusion loop asymmetry. Proc.Natl.Acad.Sci.USA (2021)
- Release Date
- 2021-09-01
- Peptides
- Envelope protein E: ACEGIKMOQSUWY02
Membrane protein M: BDFHJLNPRTVXZ13 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
EG
AI
CK
EM
AO
CQ
ES
AU
CW
EY
A0
C2
EB
BD
DF
FH
BJ
DL
FN
BP
DR
FT
BV
DX
FZ
B1
D3
F